We are live on ! Find out more
CLVS

Clovis Oncology, Inc.
CLVS

Delisted

CLVS was delisted on the 20th of December, 2022.

Back to rankings

186 hedge funds and large institutions have $1.24B invested in Clovis Oncology, Inc. in 2019 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 62 increasing their positions, 49 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 18

30% more capital invested

Capital invested by funds: $953M → $1.24B (+$285M)

27% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 49

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

21% more call options, than puts

Call options by funds: $50.7M | Put options by funds: $41.8M

13% more funds holding

Funds holding: 165 → 186 (+21)

Holders
186
Holders Change
+21
Holders Change %
+12.73%
% of All Funds
4.03%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
40
Increased
62
Reduced
49
Closed
18
Calls
$50.7M
Puts
$41.8M
Net Calls
+$8.91M
Net Calls Change
-$15.7M

Top Buyers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
+$35.1M
2
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$20.2M
3
RG
Redmile Group
California
+$12.6M
4
CS
Candriam SCA
Luxembourg
+$12.2M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$11.5M

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$73.6M
2
CCM
Camber Capital Management
Massachusetts
-$32.6M
3
PC
PointState Capital
New York
-$18.7M
4
SC
Samlyn Capital
New York
-$15.9M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$15.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Creative Planning
51
Creative Planning
Kansas
$3.46M +$37.9K +1,513 +1%
CM
52
Castleark Management
Illinois
$3.15M +$3.18M +126,739 New
Capital International Investors
53
Capital International Investors
California
$2.95M – – –
NIP
54
Nicholas Investment Partners
California
$2.84M +$896K +35,723 +45%
TA
55
Teachers Advisors
New York
$2.53M +$82.9K +3,305 +3%
VVM
56
Versant Venture Management
California
$2.53M – – –
UONDDL
57
University of Notre Dame du Lac
Indiana
$2.52M -$957K -38,183 -27%
Macquarie Group
58
Macquarie Group
Australia
$2.49M – – –
CSS
59
Cubist Systematic Strategies
Connecticut
$2.45M +$2.22M +88,367 +855%
SG Americas Securities
60
SG Americas Securities
New York
$2.41M +$1.3M +51,947 +115%
KAM
61
Kazazian Asset Management
Florida
$2.4M -$239K -9,522 -9%
Swiss National Bank
62
Swiss National Bank
Switzerland
$2.27M +$70.2K +2,800 +3%
FAM
63
Fred Alger Management
New York
$2.24M +$304K +12,115 +15%
Principal Financial Group
64
Principal Financial Group
Iowa
$2.11M +$137K +5,481 +7%
TCM
65
Tekla Capital Management
Massachusetts
$1.87M – – –
California State Teachers Retirement System (CalSTRS)
66
California State Teachers Retirement System (CalSTRS)
California
$1.81M -$40.6K -1,621 -2%
Barclays
67
Barclays
United Kingdom
$1.8M -$67.5K -2,694 -4%
GC
68
Guggenheim Capital
Illinois
$1.75M -$234K -9,323 -12%
PPA
69
Parametric Portfolio Associates
Washington
$1.71M +$432K +17,231 +33%
SI
70
Sofinnova Investments
California
$1.65M -$5.54M -221,134 -77%
State of Wisconsin Investment Board
71
State of Wisconsin Investment Board
Wisconsin
$1.64M +$431K +17,200 +35%
CWG
72
C WorldWide Group
Denmark
$1.58M -$124K -4,962 -7%
RhumbLine Advisers
73
RhumbLine Advisers
Massachusetts
$1.57M -$17.2K -685 -1%
Susquehanna International Group
74
Susquehanna International Group
Pennsylvania
$1.54M -$15.1M -603,466 -91%
Hudson Bay Capital Management
75
Hudson Bay Capital Management
Connecticut
$1.49M +$251K +10,000 +20%
1 2
3
4 5

CLVS Hedge Fund Activity: Q1 2019 in Review

186 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q1 2019, worth a combined $1.24B — up 30% from $953M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new CLVS positions and 18 closed out — a net gain of 22 holders — while 62 added to existing stakes and 49 trimmed.

The largest buyer was HealthCor Management, opening a new position worth an estimated $35.1M. The largest seller was Armistice Capital, cutting an estimated $73.6M.

  • 186 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q1 2019, up from 165 in Q4 2018.
  • Funds reported $1.24B of Clovis Oncology, Inc. stock for Q1 2019, up 30% quarter-over-quarter.
  • 40 funds opened new Clovis Oncology, Inc. positions in Q1 2019 and 18 closed out, a net change of +22 holders.
  • The largest Clovis Oncology, Inc. buyer in Q1 2019 was HealthCor Management, an estimated $35.1M added.
  • The largest Clovis Oncology, Inc. seller in Q1 2019 was Armistice Capital, an estimated $73.6M sold.

Based on aggregated 13F filings for Q1 2019.